| Authors: |
Bajwa A; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Zhao Q; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Geer M; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI., Lin C; Duke Cancer Center, Division of Hematology, Duke University, Durham, NC., Westholder J; Masonic Cancer Center, Division of Hematology and Oncology, University of Minnesota, Minneapolis, MN., Maakaron J; Masonic Cancer Center, Division of Hematology and Oncology, University of Minnesota, Minneapolis, MN., Ghosh M; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI., Frame D; Rogel Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI., Galal A; Duke Cancer Center, Division of Hematology, Duke University, Durham, NC., Tossey J; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Ahmed N; University of Kansas Cancer Center, Division of Hematologic Malignancies and Cellular Therapeutics, Overland Park, KS., Bezerra E; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Denlinger N; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., de Lima M; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Epperla N; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH., Caimi P; Taussig Cancer Institute, Division of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH., Voorhees T; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH. |
